History of Aphria:
- Founded in 2013 by Cole Cacciavillani and John Cervini.
- Vic Neufeld, former CEO of Jamieson Laboratories, led the company in its formative years.
- Listed on the Toronto Stock Exchange in March 2017.
- Granted a license by Health Canada to produce and sell medical cannabis in 2014.
- Acquired Broken Coast Cannabis in January 2018.
Tilray Merger:
- Executed a reverse acquisition to merge with Tilray in December 2020.
- Strategic move to leverage Tilray’s business assets and public trading exposure.
- Irwin Simon appointed as CEO and chairman of the merged entity.
- Decision to retain Tilray’s name and trade on NASDAQ.
- Global market potential for cannabis products estimated at $94 billion by 2025.
Business Developments:
- Transition of Aphria to NASDAQ from NYSE.
- Acquisition details of Broken Coast Cannabis.
- Agreement with Southern Glazers for cannabis distribution.
Industry Impact:
- Changes in U.S. marijuana policy affecting the Canadian industry.
- Creation of the largest cannabis company through the Aphria-Tilray merger.
Related Topics:
Aphria (company) Data Sources
| Reference | URL |
|---|---|
| Glossary | https:/glossary/aphria-company |
| Wikipedia | https://en.wikipedia.org/wiki/Aphria_(company) |
| Wikidata | https://www.wikidata.org/wiki/Q48814381 |
| Knowledge Graph | https://www.google.com/search?kgmid=/g/11f3w6dk6_ |
| DBPedia | http://dbpedia.org/resource/Aphria_(company) |
| Product Ontology | http://www.productontology.org/id/Aphria_(company) |